Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 251458-15-8 | MDL No. : | MFCD13192201 |
Formula : | C11H13BrO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZTBCOZQPDZZCJO-UHFFFAOYSA-N |
M.W : | 257.12 | Pubchem ID : | 24777892 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 59.5 |
TPSA : | 26.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.5 cm/s |
Log Po/w (iLOGP) : | 2.78 |
Log Po/w (XLOGP3) : | 3.33 |
Log Po/w (WLOGP) : | 2.9 |
Log Po/w (MLOGP) : | 3.26 |
Log Po/w (SILICOS-IT) : | 3.11 |
Consensus Log Po/w : | 3.08 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.65 |
Solubility : | 0.0574 mg/ml ; 0.000223 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.56 |
Solubility : | 0.071 mg/ml ; 0.000276 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.15 |
Solubility : | 0.0181 mg/ml ; 0.0000703 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.9 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 50℃; for 2 h; Inert atmosphere Stage #2: at 20 - 40℃; |
Sodium hydride (60percent in oil) (10.4 g, 436 mmol) was added to tetrahydrofuran (400 ml) under argon and heated with stirring to 50° C. Methyl 2-(3-bromophenyl)acetate (20 g, 87.3 mmol) was added drop wise over 30 minutes and heating continued for 90 minutes. The temperature was lowered to below 40° C. and methyl iodide (13 ml, 209 mmol) was added over 10 minutes. The resulting suspension was stirred at room temperature overnight. Water (300 ml) was carefully added and reaction mixture concentrated. Residue was partitioned between diethyl ether (400 ml) and water. The aqueous layer was extracted with diethyl ether (400 ml), and the combined ethereal extracts were dried over sodium sulfate and concentrated. Crude oil was purified by column chromatography, eluding with a gradient from 0percent to 20percent ethyl acetate in heptane to give methyl 2-(3-bromophenyl)-2-methylpropanoate (14.96 g, 58 mmol, 67percent). 1H NMR (400 MHz, CDCl3): δ ppm 7.47 (t, 1H), 7.37 (dt, 1H), 7.24 (dt, 1H), 7.18 (t, 1H), 3.65 (s, 3H), 1.55 (s, 6H) |
51% | Stage #1: With sodium hydride In tetrahydrofuran for 0.25 h; Stage #2: at 20℃; |
Example 4A: methyl 2-(3-bromophenyl)-2-methylpropanoate j00218j Example 5A (154 mg, 0.672 mmol) was dissolved in THF (2.24 mL). Sodium hydride (46.8 mg, 1.95 mmol) was added and the reaction was stirred for 15 minutes.Methyl iodide (807 iL) was added and the reaction was allowed to stir overnight at ambient temperature. The reaction was quenched with water and extracted twice with EtOAc. The combined organic extracts were washed with brine, dried (Na2SO4), filtered, and concentrated in vacuo. The crude material was purified by silica gel column chromatography (0 to 100percent EtOAc in hexanes) to yield Example 4A (87.5 mg, 51percent) as aclear oil. 1H NMR (400 MHz, CHLOROFORM-d) ö ppm 7.48 (1 H, t, J=1.88 Hz), 7.37 (1 H, dt, J=7.78, 1.51 Hz), 7.23 - 7.28 (1 H, m), 7.20 (1 H, d, J=7.78 Hz), 3.65 (3 H, s), 1.56(6 H, s). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | With acetic acid In sulfuric acid; water | a 2-Methyl-2-[3-bromophenyl]propionic Acid Methyl Ester 2-Methyl-2-[3-bromophenyl]propionitrile (0.56 g, 2.5 mmol) was refluxed in sulfuric acid (2 ml), water (3 ml) and acetic acid (2.5 ml) overnight. The reaction mixture was poured in water, then extracted with Et2O. The combined organic extracts were dried with magnesium sulfate, filtered, concentrated, and chromatographed (silica gel, 10percent EtOAc, 1percent HOAc) to give the title compound as a white solid (0.2 g, 36percent), which was converted to the methyl ester with diazo methane in Et2O and was used in the next reaction without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | Stage #1: With methanol; sodium hydroxide In tetrahydrofuran for 2 h; Reflux Stage #2: With hydrogenchloride In water |
INTERMEDIATE 82-(3 -Bromophenyl)-2-methylpropionic acidSodium hydroxide (2M, 20 mL) was added to a solution of Intermediate 7 (6.5 g) in MeOH (20 mL) and THF (20 mL). The resulting mixture was refluxed for 2 h. The mixture was evaporated, and the residue partitioned between water and DCM (100 mL each). The aqueous phase was acidified (2M hydrochloric acid) and extracted with DCM (100 mL then 50 mL). The combined organic phases were dried (MgSO4) and the solvent removed in vacuo to give the title compound (4.55 g, 68percent over two steps) as a cream solid. δH (CDCl3) 7.54 (s, IH), 7.40 (d, IH), 7.33 (d, IH), 7.21 (t, IH), 1.59 (s, 6H). |
[ 154825-97-5 ]
Methyl 2-(4-bromophenyl)-2,2-dimethylacetate
Similarity: 0.98
[ 80622-53-3 ]
Methyl 2-(3-bromophenyl)propanoate
Similarity: 0.98
[ 1236357-65-5 ]
Methyl 1-(4-bromophenyl)cyclobutanecarboxylate
Similarity: 0.94
[ 32454-36-7 ]
Ethyl 2-(4-bromophenyl)-2-methylpropanoate
Similarity: 0.94
[ 1215205-50-7 ]
Ethyl 1-(4-bromophenyl)cyclopropanecarboxylate
Similarity: 0.91
[ 154825-97-5 ]
Methyl 2-(4-bromophenyl)-2,2-dimethylacetate
Similarity: 0.98
[ 80622-53-3 ]
Methyl 2-(3-bromophenyl)propanoate
Similarity: 0.98
[ 1236357-65-5 ]
Methyl 1-(4-bromophenyl)cyclobutanecarboxylate
Similarity: 0.94
[ 32454-36-7 ]
Ethyl 2-(4-bromophenyl)-2-methylpropanoate
Similarity: 0.94
[ 1215205-50-7 ]
Ethyl 1-(4-bromophenyl)cyclopropanecarboxylate
Similarity: 0.91
[ 154825-97-5 ]
Methyl 2-(4-bromophenyl)-2,2-dimethylacetate
Similarity: 0.98
[ 80622-53-3 ]
Methyl 2-(3-bromophenyl)propanoate
Similarity: 0.98
[ 1236357-65-5 ]
Methyl 1-(4-bromophenyl)cyclobutanecarboxylate
Similarity: 0.94
[ 32454-36-7 ]
Ethyl 2-(4-bromophenyl)-2-methylpropanoate
Similarity: 0.94
[ 1215205-50-7 ]
Ethyl 1-(4-bromophenyl)cyclopropanecarboxylate
Similarity: 0.91